Advertisement

Topische Antibiotikatherapie: Was wirkt? Gefährliche Resistenzentwicklung?

  • Dietrich Abeck
Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 14)

Zusammenfassung

Die Ätiologie der Acne vulgaris ist multifaktoriell (Abb.1). Der Einsatz eines Antibiotikums bei der Acne vulgaris, unabhängig davon, ob topisch oder systemisch, setzt sich mit einem ganz bestimmten Teilfaktor auseinander, nämlich der mikrobiellen Besiedelung der Talgdrüsenfollikel.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Akamatsu H, Niwa Y, Kurokawa I et al (1991) Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism. Arch Dermatol Res 283:524–528.PubMedCrossRefGoogle Scholar
  2. 2.
    Akamatsu H, Kurokawa I, Nishijima S, Asada Y (1992) Inhibition of neutrophilic chemotactic factor produc tion in comedonal bacteria by subminimal inhibitory concentrations of erythromycin. Dermatologica 185:41–43.CrossRefGoogle Scholar
  3. 3.
    Bojar RA, Eady EA, Jones CE, Cuncliffe WJ, Holland KT (1994) Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topi cal erythromycin with and without zinc. Br J Derma tol 130:329–336.CrossRefGoogle Scholar
  4. 4.
    Chalker DK, Shalita A, Smith JG, Swann RW (1983) A double-blind study of the effectiveness of a 3% eryth romycin and a 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 9:933–936.PubMedCrossRefGoogle Scholar
  5. 5.
    Eady EA, Cove JH, Holland KT, Cuncliffe WJ (1989) Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic fai lure. Br J Dermatol 121:51–57.PubMedCrossRefGoogle Scholar
  6. 6.
    Eady EA, Jones CE, Tipper JL et al (1993) Antibiotic re sistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J 306:555–556.CrossRefGoogle Scholar
  7. 7.
    Esterly NB, Furey NL, Flanagan LG (1978) The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 70:51–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Forssman T (1993) Antimikrobielle Akne-Therapie. Antibiotika-Resistenzen beachten. TW Dermatol 23:414–419.Google Scholar
  9. 9.
    Guin JD, Lummis WL (1982) Comedonal levels of free clindamycin following topical treatment with a 1% so lution of clindamycin phosphate. J Am Acad Derma tol 7:265–268.CrossRefGoogle Scholar
  10. 10.
    Harkaway KS, McGinley KJ, Foglia AN et al (1992) An tibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy. Br J Der matol 126:586–590.Google Scholar
  11. 11.
    Leyden JJ (1976) Antibiotic resistant acne. Cutis 17:593–596.PubMedGoogle Scholar
  12. 12.
    Naidoo J, Noble WC (1987) Skin as a source of transfe rable antibiotic resistance in coagulase-negative staphylococci. Zbl Bakt Suppl 16:225–234.Google Scholar
  13. 13.
    Noble WC (1990) Topical and systemic antibiotics: is there a rationale? Sem Dermatol 9:250–254.Google Scholar
  14. 14.
    Tucker SB, Tausend R, Cochran R, Flannigan SA (1984) Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 110:487–492.PubMedCrossRefGoogle Scholar
  15. 15.
    Webster GF, Leyden JJ (1980) Production of serum-in dependent polymorphonuclear leukocyte chemotactic factors by Propionibacterium acnes. Inflammation 4:261–269.PubMedCrossRefGoogle Scholar
  16. 16.
    Webster GF, Leyden JJ (1982) Mechanisms of Propioni bacterium acnes mediated inflammation in acne vul garis. Semin Dermatol 1:299–304.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Dietrich Abeck

There are no affiliations available

Personalised recommendations